TAGHIZADEHGHALEHJOUGHI, A. Et Al. 2021. Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29. Journal of Contemporary Medicine , vol.11, no.2 , 166-173.

TAGHIZADEHGHALEHJOUGHI, A., YENİ, Y., GENÇ, S., WALLACE, D. R., HACIMÜFTÜOĞLU, A., & ÇAKIR, Z., (2021). Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29. Journal of Contemporary Medicine , vol.11, no.2, 166-173.

TAGHIZADEHGHALEHJOUGHI, ALI Et Al. "Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29," Journal of Contemporary Medicine , vol.11, no.2, 166-173, 2021

TAGHIZADEHGHALEHJOUGHI, ALI Et Al. "Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29." Journal of Contemporary Medicine , vol.11, no.2, pp.166-173, 2021

TAGHIZADEHGHALEHJOUGHI, A. Et Al. (2021) . "Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29." Journal of Contemporary Medicine , vol.11, no.2, pp.166-173.

@article{article, author={ALI TAGHIZADEHGHALEHJOUGHI Et Al. }, title={Melatonin receptors increase Momordica’s anticancer effects against PC-3 and HT-29}, journal={Journal of Contemporary Medicine}, year=2021, pages={166-173} }